CS-747S PhaseIII trial -Non-inferiority study of CS-747S versus clopidogrel bisulfate in patients with ischemic cerebrovascular accident.-

Trial Profile

CS-747S PhaseIII trial -Non-inferiority study of CS-747S versus clopidogrel bisulfate in patients with ischemic cerebrovascular accident.-

Completed
Phase of Trial: Phase III

Latest Information Update: 03 Dec 2016

At a glance

  • Drugs Prasugrel (Primary) ; Clopidogrel
  • Indications Cerebrovascular disorders
  • Focus Therapeutic Use
  • Acronyms PRASTRO-I
  • Sponsors Daiichi Sankyo Company
  • Most Recent Events

    • 21 Oct 2016 Results published in Daiichi Sankyo media release.
    • 21 Oct 2016 Status changed from active, no longer recruiting to completed, as per Daiichi Sankyo media release.
    • 03 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top